Aelis Farma (XPAR:AELIS) Short Interest


XPAR:AELIS Aelis Farma SA XPAR:AELIS
32 GF Score
Price €1.07
GF Value €0.98
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XPAR:AELIS vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Aelis Farma's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aelis Farma Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aelis Farma's Short Interest distribution charts can be found below:

* The bar in red indicates where Aelis Farma's Short Interest falls into.


XPAR:AELIS
32GF Score
Aelis Farma SA XPAR:AELIS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aelis Farma (XPAR:AELIS) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.07 is trading 9.2% above its estimated GF Value™ of €0.98. GuruFocus considers Aelis Farma to be Fairly Valued.

Key valuation signals for XPAR:AELIS:

  • Short Interest:
  • GF Value™: €0.98 vs. price of €1.07 (9.2% above fair value)
  • GF Score™: 32/100 with 4 warning signs

No single metric tells the full story. See the XPAR:AELIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges 69O:Germany
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
32GF Score

Get the complete analysis for XPAR:AELIS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.07
Price
€0.98
GF Value